Advances in the Use of Monoclonal Antibodies for ALL
By
Dana-Farber Cancer Institute
FEATURING
Daniel J. DeAngelo
By
Dana-Farber Cancer Institute
FEATURING
Daniel J. DeAngelo
Login to view comments.
Click here to Login